Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Smoljanovic V"'
Autor:
Dziadziuszko, R., Peters, S., Ruf, T., Cardona, A., Guerini, E., Kurtsikidze, N., Smoljanovic, V., Planchard, D.
Publikováno v:
In ESMO Open December 2022 7(6)
Autor:
Wolf, J., Helland, Å., Oh, I.-J., Migliorino, M.R., Dziadziuszko, R., Wrona, A., de Castro, J., Mazieres, J., Griesinger, F., Chlistalla, M., Cardona, A., Ruf, T., Trunzer, K., Smoljanovic, V., Novello, S.
Publikováno v:
In ESMO Open February 2022 7(1)
Autor:
Mok, T., Camidge, D.R., Gadgeel, S.M., Rosell, R., Dziadziuszko, R., Kim, D.-W., Pérol, M., Ou, S.-H.I., Ahn, J.S., Shaw, A.T., Bordogna, W., Smoljanović, V., Hilton, M., Ruf, T., Noé, J., Peters, S.
Publikováno v:
In Annals of Oncology August 2020 31(8):1056-1064
Autor:
Gadgeel S, Shaw AT, Barlesi F, Crino L, Yang JCH, Dingemans AM, Kim DW, de Marinis F, Schulz M, Liu S, Gupta R, Smoljanovic V, Ou SHI
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 10, Pp 125-130 (2019)
Shirish Gadgeel,1 Alice T Shaw,2 Fabrice Barlesi,3 Lucio Crino,4 James CH Yang,5 Anne-Marie Dingemans,6 Dong-Wan Kim,7 Filippo de Marinis,8 Mathias Schulz,8 Shiyao Liu,9 Ravindra Gupta,9 Vlatka Smoljanovic,10 Sai-Hong Ignatius Ou11 1Department of Int
Externí odkaz:
https://doaj.org/article/be4ff09e7ee3407b8b960a718417af5e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Noé J; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Bordogna W; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Archer V; Roche Products Ltd., Welwyn, United Kingdom., Smoljanovic V; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Hilton M; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Woodhouse R; Foundation Medicine Inc., Cambridge, Massachusetts., Mocci S; Genentech, Inc., South San Francisco, California., Gadgeel SM; Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2022 May 18; Vol. 3 (7), pp. 100341. Date of Electronic Publication: 2022 May 18 (Print Publication: 2022).
Autor:
Dziadziuszko R; Medical University of Gdańsk, Gdańsk, Poland., Peters S; Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Mok T; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China., Camidge DR; University of Colorado, Denver, Colorado., Gadgeel SM; Department of Internal Medicine, Henry Ford Cancer Institute/Henry Ford Health System, Detroit, Michigan., Ou SI; Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, California., Konopa K; Medical University of Gdańsk, Gdańsk, Poland., Noé J; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Nowicka M; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Bordogna W; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Morcos PN; F. Hoffmann-La Roche Ltd., New York, New York., Smoljanovic V; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Shaw AT; Massachusetts General Hospital, Boston, Massachsuetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 May 02; Vol. 28 (9), pp. 1800-1808.
Importance: Bevacizumab treatment beyond progression has been investigated in breast and metastatic colorectal cancers. Avastin in All Lines Lung (AvaALL) is the first randomized phase 3 study of bevacizumab across multiple lines of treatment beyond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::9be2de486b8e3a874f351db90d4f4eeb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086285
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086285
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Krebs, M.G., Lin, J.J., Pal, N., Polito, L., Trinh, H.T.L., Hilton, M.M.S.M., Smoljanovic, V., Kurtsikidze, N., Archer, V., Zhang, Q.
Publikováno v:
In Annals of Oncology September 2021 32 Supplement 5:S959-S959